HUP0004802A3 - Nicotine compositions and methods of formulation thereof - Google Patents
Nicotine compositions and methods of formulation thereofInfo
- Publication number
- HUP0004802A3 HUP0004802A3 HU0004802A HUP0004802A HUP0004802A3 HU P0004802 A3 HUP0004802 A3 HU P0004802A3 HU 0004802 A HU0004802 A HU 0004802A HU P0004802 A HUP0004802 A HU P0004802A HU P0004802 A3 HUP0004802 A3 HU P0004802A3
- Authority
- HU
- Hungary
- Prior art keywords
- formulation
- methods
- nicotine compositions
- nicotine
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 2
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 229960002715 nicotine Drugs 0.000 title 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Dispersion Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9703458A SE9703458D0 (sv) | 1997-09-25 | 1997-09-25 | Nicotine compositions and methods of formulation thereof |
PCT/SE1998/001632 WO1999015171A1 (en) | 1997-09-25 | 1998-09-15 | Nicotine compositions and methods of formulation thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0004802A2 HUP0004802A2 (hu) | 2001-05-28 |
HUP0004802A3 true HUP0004802A3 (en) | 2001-12-28 |
Family
ID=20408364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0004802A HUP0004802A3 (en) | 1997-09-25 | 1998-09-15 | Nicotine compositions and methods of formulation thereof |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1023069B1 (hu) |
JP (1) | JP2001517624A (hu) |
KR (1) | KR20010024305A (hu) |
CN (1) | CN1123343C (hu) |
AT (1) | ATE253362T1 (hu) |
AU (1) | AU733619B2 (hu) |
BR (1) | BR9815395A (hu) |
CA (1) | CA2304042A1 (hu) |
DE (1) | DE69819548T2 (hu) |
DK (1) | DK1023069T3 (hu) |
EE (1) | EE200000154A (hu) |
ES (1) | ES2210817T3 (hu) |
FI (1) | FI20000692A (hu) |
HU (1) | HUP0004802A3 (hu) |
MX (1) | MXPA00002955A (hu) |
NO (1) | NO20001540L (hu) |
NZ (1) | NZ503408A (hu) |
PT (1) | PT1023069E (hu) |
RU (1) | RU2201747C2 (hu) |
SE (1) | SE9703458D0 (hu) |
WO (1) | WO1999015171A1 (hu) |
ZA (1) | ZA988794B (hu) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6638621B2 (en) * | 2000-08-16 | 2003-10-28 | Lyotropic Therapeutics, Inc. | Coated particles, methods of making and using |
US8256433B2 (en) | 1999-07-16 | 2012-09-04 | Aradigm Corporation | Systems and methods for effecting cessation of tobacco use |
US6799576B2 (en) | 1999-07-16 | 2004-10-05 | Aradigm Corporation | System for effecting smoking cessation |
AT409219B (de) * | 1999-08-13 | 2002-06-25 | Red Bull Gmbh | Verwendung von nikotin zum herstellen von arzneimitteln |
KR100381622B1 (ko) * | 2000-08-30 | 2003-04-26 | 디디에스텍주식회사 | 자극성을 줄인 염기성 약물의 구강 투여 조성물 |
DE10057769A1 (de) * | 2000-11-22 | 2002-05-23 | Beiersdorf Ag | Haarpflegeprodukte mit einem Gehalt an dispersen Flüssigkristallen, welche kubische Phasen darstellen |
SE521512C2 (sv) | 2001-06-25 | 2003-11-11 | Niconovum Ab | Anordning för administrering av en substans till främre delen av en individs munhåla |
WO2003082240A1 (de) * | 2002-03-30 | 2003-10-09 | Beisel Guenther | Zubereitung enthaltend fettsäure zur appetitminderung, sättigung und/oder gewichtsreduktion |
US20040002520A1 (en) * | 2002-07-01 | 2004-01-01 | Soderlund Patrick L. | Composition and method for cessation of Nicotine cravings |
KR100443722B1 (ko) * | 2002-09-26 | 2004-08-09 | 이용원 | 니코틴을 함유한 하드츄잉캔디 및 그의 제조방법 |
PT1578422E (pt) | 2002-12-20 | 2007-06-14 | Niconovum Ab | Material particulado contendo nicotina fisicamente e quimicamente estável |
FR2851470B1 (fr) * | 2003-02-20 | 2007-11-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse |
US10172810B2 (en) | 2003-02-24 | 2019-01-08 | Pharmaceutical Productions, Inc. | Transmucosal ketamine delivery composition |
US9254294B2 (en) | 2003-02-24 | 2016-02-09 | Pharmaceutical Productions Inc. | Transmucosal hormone delivery system |
US9498454B2 (en) * | 2003-02-24 | 2016-11-22 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
US9358296B2 (en) | 2003-02-24 | 2016-06-07 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
JP5475215B2 (ja) * | 2003-02-24 | 2014-04-16 | ファーマシューティカル プロダクションズ, インコーポレイテッド | 経粘膜薬物送達システム |
GB0322033D0 (en) * | 2003-09-19 | 2003-10-22 | Camurus Ab | Composition |
JP4931596B2 (ja) | 2003-11-07 | 2012-05-16 | ユーエス スモークレス タバコ カンパニー リミテッド ライアビリティ カンパニー | タバコ組成物 |
US8627828B2 (en) | 2003-11-07 | 2014-01-14 | U.S. Smokeless Tobacco Company Llc | Tobacco compositions |
US7125954B2 (en) | 2005-01-27 | 2006-10-24 | General Electric Company | Method for producing polyether polymers |
US20080219935A1 (en) * | 2005-07-08 | 2008-09-11 | Sang-Hoon Kwak | Phase Transitive Breath Care Products |
JP5694645B2 (ja) | 2006-03-16 | 2015-04-01 | ニコノヴァム エービーNiconovum Ab | 改善された嗅ぎたばこ組成物 |
US20100247653A1 (en) * | 2006-04-11 | 2010-09-30 | Hans Lautenschlager | Nanoparticles containing nicotine and/or cotinine, dispersions, and use thereof |
US20080287507A1 (en) * | 2007-05-16 | 2008-11-20 | John Hedenstrom | Nicotine containing toiletry waters |
GB2469792A (en) * | 2009-04-23 | 2010-11-03 | Calvin John Ross | Oil-based pharmaceutical formulation for sublingual delivery |
GB2476471A (en) * | 2009-12-22 | 2011-06-29 | Norwich Pharma Technologies Ltd | Cotinine formulation for the treatment of obesity |
US8846725B2 (en) * | 2011-01-24 | 2014-09-30 | Quadex Pharmaceuticals, Llc | Highly penetrating compositions and methods for treating pathogen-induced disordered tissues |
CN102552405B (zh) * | 2012-03-21 | 2013-10-16 | 张伟 | 一种肛周术后麻醉镇痛的药物组合物的制备方法 |
CN103040741B (zh) * | 2012-12-11 | 2014-11-05 | 中山大学 | 溶致液晶的前体混悬液及其制备方法 |
US20160015703A1 (en) * | 2013-03-07 | 2016-01-21 | Danmarks Tekniske Universitet | Nano- microdelivery systems for oromucosal delivery of an active ingredient |
CN114223928A (zh) * | 2013-05-06 | 2022-03-25 | 尤尔实验室有限公司 | 用于气溶胶装置的烟碱盐调配物及其方法 |
WO2015090337A1 (en) * | 2013-12-20 | 2015-06-25 | Fertin Pharma A/S | Nicotine powder composition |
US20150283070A1 (en) * | 2014-04-08 | 2015-10-08 | Sansa Corporation (Barbados) Inc. | Nicotine Formulations and Methods of Making the Same |
GB201414919D0 (en) * | 2014-08-21 | 2014-10-08 | Corbitt Terence Simon | Formulations for transmucosal delivery |
CN108323791B (zh) * | 2018-01-03 | 2021-02-12 | 云南中烟工业有限责任公司 | 一种尼古丁-氧化锌复合物、其制备方法及包含其的烟草制品 |
JP2021530431A (ja) * | 2018-04-16 | 2021-11-11 | ポビバ コーポレーションPoviva Corp. | ニコチン化合物を含ませた組成物及び其れ等の使用の方法 |
CN109125251B (zh) * | 2018-09-10 | 2021-08-13 | 武汉百纳礼康生物制药有限公司 | 一种包载蛋白类药物的温敏性液晶凝胶制剂及其制备方法 |
KR102186704B1 (ko) | 2019-02-18 | 2020-12-04 | (주)아이엠디팜 | 서방성 지질 전구 제제 및 이를 포함하는 지질 용액 형태의 서방성 주사용 약학 조성물 |
LU101520B1 (en) * | 2019-12-02 | 2021-06-07 | Herrera Arturo Solis | (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a homogeneous, viscous, semi-solid topical medication and topical medication |
LU101511B1 (en) * | 2019-12-02 | 2021-06-04 | Herrera Arturo Solis | (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a parenteral administration and a process for the preparation of an injectable substance |
NL2031331B1 (en) | 2022-03-18 | 2023-09-29 | Plethora Therapeutics B V | Transmucosal delivery of a short-acting psychedelic compound |
NL2031332B1 (en) | 2022-03-18 | 2023-09-29 | Plethora Therapeutics B V | Transmucosal delivery of psychoactive compounds |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5371109A (en) * | 1986-07-01 | 1994-12-06 | Drilletten Ab | Controlled release composition for a biologically active material dissolved or dispersed in an L2-phase |
IL86170A (en) * | 1987-05-01 | 1992-12-01 | Elan Transdermal Ltd | Preparations and compositions comprising nicotine for percutaneous administration |
US4908213A (en) * | 1989-02-21 | 1990-03-13 | Schering Corporation | Transdermal delivery of nicotine |
GB2230439A (en) * | 1989-04-20 | 1990-10-24 | Alec Stanley Walter Shaw | Nicotine lozenges |
JP3571717B2 (ja) * | 1991-10-04 | 2004-09-29 | ゲー・エス・デイベロツプメント・アクチエボラーグ | 粒子、該粒子の製法及びその使用 |
WO1997013528A1 (en) * | 1995-10-12 | 1997-04-17 | Gs Development Ab | A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface |
-
1997
- 1997-09-25 SE SE9703458A patent/SE9703458D0/xx unknown
-
1998
- 1998-09-15 EE EEP200000154A patent/EE200000154A/xx unknown
- 1998-09-15 MX MXPA00002955A patent/MXPA00002955A/es not_active IP Right Cessation
- 1998-09-15 DK DK98945685T patent/DK1023069T3/da active
- 1998-09-15 BR BR9815395-1A patent/BR9815395A/pt not_active IP Right Cessation
- 1998-09-15 WO PCT/SE1998/001632 patent/WO1999015171A1/en not_active Application Discontinuation
- 1998-09-15 AT AT98945685T patent/ATE253362T1/de not_active IP Right Cessation
- 1998-09-15 AU AU92872/98A patent/AU733619B2/en not_active Ceased
- 1998-09-15 RU RU2000110632/14A patent/RU2201747C2/ru not_active IP Right Cessation
- 1998-09-15 PT PT98945685T patent/PT1023069E/pt unknown
- 1998-09-15 JP JP2000512540A patent/JP2001517624A/ja active Pending
- 1998-09-15 NZ NZ50340898A patent/NZ503408A/xx unknown
- 1998-09-15 KR KR1020007003204A patent/KR20010024305A/ko not_active Application Discontinuation
- 1998-09-15 EP EP98945685A patent/EP1023069B1/en not_active Expired - Lifetime
- 1998-09-15 CN CN98810645A patent/CN1123343C/zh not_active Expired - Fee Related
- 1998-09-15 CA CA002304042A patent/CA2304042A1/en not_active Abandoned
- 1998-09-15 ES ES98945685T patent/ES2210817T3/es not_active Expired - Lifetime
- 1998-09-15 HU HU0004802A patent/HUP0004802A3/hu unknown
- 1998-09-15 DE DE69819548T patent/DE69819548T2/de not_active Expired - Fee Related
- 1998-09-25 ZA ZA988794A patent/ZA988794B/xx unknown
-
2000
- 2000-03-24 FI FI20000692A patent/FI20000692A/fi not_active IP Right Cessation
- 2000-03-24 NO NO20001540A patent/NO20001540L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DK1023069T3 (da) | 2004-03-08 |
SE9703458D0 (sv) | 1997-09-25 |
WO1999015171A1 (en) | 1999-04-01 |
KR20010024305A (ko) | 2001-03-26 |
AU733619B2 (en) | 2001-05-17 |
PT1023069E (pt) | 2004-02-27 |
NO20001540D0 (no) | 2000-03-24 |
HUP0004802A2 (hu) | 2001-05-28 |
DE69819548D1 (de) | 2003-12-11 |
AU9287298A (en) | 1999-04-12 |
CN1278174A (zh) | 2000-12-27 |
EE200000154A (et) | 2001-02-15 |
EP1023069A1 (en) | 2000-08-02 |
ATE253362T1 (de) | 2003-11-15 |
ZA988794B (en) | 1999-04-01 |
NO20001540L (no) | 2000-05-25 |
ES2210817T3 (es) | 2004-07-01 |
NZ503408A (en) | 2004-12-24 |
CA2304042A1 (en) | 1999-04-01 |
DE69819548T2 (de) | 2004-08-12 |
JP2001517624A (ja) | 2001-10-09 |
BR9815395A (pt) | 2000-11-14 |
RU2201747C2 (ru) | 2003-04-10 |
FI20000692A (fi) | 2000-03-24 |
CN1123343C (zh) | 2003-10-08 |
MXPA00002955A (es) | 2002-04-24 |
EP1023069B1 (en) | 2003-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0004802A3 (en) | Nicotine compositions and methods of formulation thereof | |
EP0960019A4 (en) | METHOD FOR PRODUCING REPLICAS AND COMPOSITIONS USED THEREFOR | |
HK1036225A1 (en) | Peptide compositions and formulations and use of same | |
PL341566A1 (en) | Oral composition of yttraconasole preparation and method of obtaining same | |
PL327658A1 (en) | Disinfecting compositions and methods of disinfecting surfaces | |
SG83678A1 (en) | Additive preparation and method of use thereof | |
GB9422571D0 (en) | Haemorrihoidal compositions and method of use | |
HUP9702035A3 (en) | Inhibitors of leukocita-adhesion- and vla-4-antagonists and pharmaceutical compositions containing them | |
HUP9702036A3 (en) | Inhibitors of leucocita-adhesion and wla-4-antagonists and pharmaceutical compositions containing them | |
HUP9702034A3 (en) | Inhibitors of leukocita-adhesion and vla-4-antagonists and pharmaceutical compositions containing them | |
AU5699799A (en) | Makeup compositions and methods of making same | |
IL140214A0 (en) | Butterlike compositions and methods of manufacturing same | |
EP1227821A4 (en) | THERAPEUTIC COMPOSITIONS AND METHOD FOR USE THEREOF | |
ZA971964B (en) | Azolobenzazepine derivatives and compositions and method of use thereof. | |
AUPO727097A0 (en) | Method of treatment of hepatoma and pharmaceutical compositions for use therein | |
PT977812E (pt) | Composições asfálticas e respectivos métodos de preparação | |
GB2327190B (en) | Process for the preparation of depilatory compositions and their use | |
GB9710800D0 (en) | Pharmaceutical composition and method of preparing it | |
EP1181022A4 (en) | MEDICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF | |
PL339619A1 (en) | Compositions containing copolymers of polyphenoles and method of obtaining such compositions | |
PL327945A1 (en) | Disinfecting compositions and methods of disinfecting surfaces | |
HK1029497A1 (en) | Enhanced flavoring compositions containing n-ethyl-p-methane-3-carboxamide and method of making and using same | |
PL317374A1 (en) | Maltitol composition and method of obtaining same | |
EG21177A (en) | Insecticidal aerosol composition and insecticidal composition for preparation of same | |
EP1139981A4 (en) | COMPOSITIONS AND RELATED METHODS OF USE |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |